189 related articles for article (PubMed ID: 36924631)
21. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
22. Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Pandey A; Price A; Ayala-Lopez N; Garza KY; Marzinke MA; Knezevic CE
J Pharm Biomed Anal; 2024 Jun; 243():116082. PubMed ID: 38461636
[TBL] [Abstract][Full Text] [Related]
23. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
24. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
Hummert P; Parsons TL; Ensign LM; Hoang T; Marzinke MA
J Pharm Biomed Anal; 2018 Apr; 152():248-256. PubMed ID: 29433097
[TBL] [Abstract][Full Text] [Related]
25. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
Abdalla KA; Shabaan MM; Stanczyk FZ
Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
[TBL] [Abstract][Full Text] [Related]
26. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
Crook D; Godsland IF; Wynn V
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
[TBL] [Abstract][Full Text] [Related]
28. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
29. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
Hofmeyr GJ; Singata-Madliki M; Batting J; Balakrishna Y; Morroni C
BMC Womens Health; 2024 Mar; 24(1):167. PubMed ID: 38459552
[TBL] [Abstract][Full Text] [Related]
30. No-daily hormonal contraception today: general overview and application in specific clinical settings.
Bounous VE; Actis S; Rosso R; Giorgi M; Tiranini L; Nappi RE; Biglia N
Gynecol Endocrinol; 2023 May; 39(1):2214626. PubMed ID: 37199597
[TBL] [Abstract][Full Text] [Related]
31. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
[TBL] [Abstract][Full Text] [Related]
32. Long-acting steroids provide new options.
Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
[TBL] [Abstract][Full Text] [Related]
33. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
34. [Information on advances in sciences and technology. Advances in contraceptive technology].
Andrade AT
Bol Cent Biol Reprod; 1993; 12(1):51-2. PubMed ID: 12345521
[TBL] [Abstract][Full Text] [Related]
35. Rapid Quantification of Medroxyprogesterone Acetate (MPA) in Human Plasma by LC-MS/MS.
Hummert P; Manohar M; Aung WS; Marzinke MA
J Appl Lab Med; 2016 Sep; 1(2):202-213. PubMed ID: 33626792
[TBL] [Abstract][Full Text] [Related]
36. A fit-for-purpose LC-MS/MS method for the simultaneous quantitation of ATP and 2,3-DPG in human K
Kim H; Kosinski P; Kung C; Dang L; Chen Y; Yang H; Chen YS; Kramer J; Liu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():89-96. PubMed ID: 28711785
[TBL] [Abstract][Full Text] [Related]
37. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
[TBL] [Abstract][Full Text] [Related]
38. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
39. Differential off-target glucocorticoid activity of progestins used in endocrine therapy.
Komane M; Avenant C; Louw-du Toit R; Africander DJ; Hapgood JP
Steroids; 2022 Jun; 182():108998. PubMed ID: 35271867
[TBL] [Abstract][Full Text] [Related]
40. Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis.
Parsons TL; Emory JF; Seserko LA; Aung WS; Marzinke MA
J Pharm Biomed Anal; 2014 Sep; 98():407-16. PubMed ID: 25005891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
